ProKidney Corp. Noncontrolling Interest, Increase from Subsidiary Equity Issuance
ProKidney Corp. (PROK) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $14.79 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements
us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2025-03-17
- ProKidney Corp. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2024-03-31 was $8.67M, a 131.07% increase year-over-year.
- ProKidney Corp. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2023-12-31 was $338.00K, a 133.10% increase year-over-year.
- ProKidney Corp. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2023-09-30 was $21.00K, a 88.07% decline year-over-year.
- ProKidney Corp. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2023-06-30 was $725.00K.
- ProKidney Corp. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2024 was $14.79M, a 208.36% increase from fiscal 2023.
- ProKidney Corp. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2023 was $4.79M, a 1393.77% increase from fiscal 2022.
- ProKidney Corp. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2022 was $321.00K.
| Period end | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 3 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 6 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 9 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month |
|---|---|---|---|---|
| 2024-12-31 | $14.79M 10-K · filed 2025-03-17 | |||
| 2024-03-31 | $8.67M 10-Q · filed 2024-05-10 | $9.01M derived: sum of 2 quarters · filed 2025-03-17 | $9.03M derived: sum of 3 quarters · filed 2025-03-17 | $9.76M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-12-31 | $338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $359.00K derived: sum of 2 quarters · filed 2025-03-17 | $1.08M derived: sum of 3 quarters · filed 2025-03-17 | $4.79M 10-K · filed 2025-03-17 |
| 2023-09-30 | $21.00K 10-Q · filed 2023-11-14 | $746.00K derived: sum of 2 quarters · filed 2023-11-14 | $4.46M 10-Q · filed 2023-11-14 | $4.64M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $725.00K 10-Q · filed 2023-08-10 | $4.48M 10-Q · filed 2023-08-10 | $4.62M derived: sum of 3 quarters · filed 2025-03-17 | $4.80M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $3.75M 10-Q · filed 2024-05-10 | $3.90M derived: sum of 2 quarters · filed 2025-03-17 | $4.07M derived: sum of 3 quarters · filed 2025-03-17 | |
| 2022-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $321.00K derived: sum of 2 quarters · filed 2025-03-17 | $321.00K 10-K · filed 2025-03-17 | |
| 2022-09-30 | $176.00K 10-Q · filed 2023-11-14 | $176.00K 10-Q · filed 2023-11-14 |